Distributors specializing in medical products and devices are vital to patient care worldwide, ensuring safe, efficient, and on-time deliveries to a range of care settings. Those focused on consumables are particularly well positioned for success thanks to their highly predictable and recurring demand.

Medical Consumables: sangro Highlights Distribution Opportunity 

Healthcare & Life Sciences

HCLS Article Sangro Web Media

Behavioral Health Q3 2026

Mother and daughter with down syndrome having fun while working on garden during daytime.

HCLS Sector Brief Behavioral Health Q2 2026 Web Media

Employers are prioritizing competitive benefits programs that meet rising employee expectations while navigating a complex regulatory and technology landscape. Handling these benefits in-house is costly and time-consuming, and most businesses aren't equipped to do it well.

Benefits Administration Technology: Compliance-Driven Demand and AI Resilience Attract Investors

Technology

TECH HCLS Article ThrivePass Web Media

Revenue Cycle Management 2H 2026

HCLS TECH Sector Brief RCM 2H 2026 Web Media

Consumers are taking a more proactive role in their health, and vitamins, minerals, and supplements (VMS) have become central to that effort.   Rising interest in preventive wellness, growing comfort with self-directed care, and an expanding number of health-conscious consumers are driving momentum across the sector. At the same time, scientific validation, cleaner formulations, and digital-first brands are elevating consumer trust and broadening adoption. 

Vitamins, Minerals, and Supplements: Investing Behind Health, Wellness, and Performance

Consumer

CONS Article VMS Web Media

Across highly regulated facilities, from hospitals and pharmaceutical suites to data centers and research labs, testing and certification are required before spaces can open, operate, and generate revenue. That non-discretionary, recurring demand has turned testing, adjusting, and balancing (TAB) and controlled environment (CE) certification into one of the more sought-after corners of the specialized services landscape.

Compliance-Driven Testing & Certification: Integra Sparks Investor Interest

Energy, Power & Infrastructure

Business Services

BS EPI Article Integra Web Media

The pharma commercialization services sector is benefiting from a powerful set of structural tailwinds—including a replenished drug development pipeline, growing complexity of novel modalities, and greater adoption of AI-driven commercialization tools—all of which are creating robust and sustained demand for third-party commercialization expertise. 

Outsourced Pharma Services: Deerfield and the Rising Demand for Commercialization

HCLS Article Deerfield Web Media

Medical Products & Devices Q2 2026

Neurosurgery OR setup. The operating room is equipped with advanced surgical instruments, monitors, and lighting for neurosurgery procedures 

HCLS Sector Brief Med Products Q2 2026 Web Media

Behavioral Health Q2 2026

Outsourced Pharma Services & Pharma Tech Q2 2026

Vials containing medicine for injections on plastic cases. 

HCLS Sector Brief Outsourced Pharma Services & Pharma Tech Q2 2026 Web Media

Life Couriers Acquired by JLL Partners

Mergers & Acquisitions

Transportation & Logistics

Outsourced Provider Services

Third-Party Logistics

7054 Life Couriers NT

Peterson Partners Completes Single-Asset Continuation Vehicle for Ennoble Care

Private Capital Solutions

Providers

7375 PCS Ennoble Care - Peterson Partners NT

Elara Caring Receives Strategic Investment From Ares and DaVita Inc.

6393 Elara Caring NT SP

ThrivePass Acquired by Shore Capital 

Payer Tech & Services

Enterprise Software

6956 ThrivePass NT SP

The Deerfield Group Receives Majority Investment from Martis Capital

Outsourced Pharma Services

6743 Deerfield Agency NT

Sangro Acquired by Axcel 

Medical Products and Devices

Specialty Distribution

6564 Sangro NT

Optimum Healthcare IT Acquired by Infosys

Vertical Software

Technology and Data Services

HCIT

6825 Optimum Healthcare IT NT

LearnWell Acquired by Goldman Sachs Alternatives

6875 LearnWell NT

Ennoble Care Receives Growth Investment Led by Partners Group and Norwest

7286 Ennoble Care NT SP

Tri-Imaging Solutions and DirectMed Imaging Merge to Create a Scaled Imaging Solutions Platform  

6801 Tri-Imaging Solutions NT

Reliable Medical Acquired by Gauge Capital 

6685 Reliable Medical NT

L Catterton Makes Strategic Investment in US Fertility in Partnership with Amulet Capital Partners

7021 US Fertility - L Catterton and Amulet Partners NT

TPG Growth Completes Continuation Vehicle for AnovoRx

Pharmacy

6829 PCA AvonoRx NT

Sheridan Capital Partners Acquires ICANotes

7371 ICANotes - Sheridan Capital Partners NT SP

Bain Capital Double Impact Acquires Legacy Hospice

7210 Legacy Hospice - Bain Capital Double Impact NT

SSI Strategy Acquired by Clinigen Group

6749 SSI Strategy NT

Ontellus Acquired by Datavant

Professional & Tech-Enabled Services

6641 Ontellus NT

Linden Capital Partners Acquires Agape Care Group

6997 Agape Care Group - Linden Capital Partners NT

HealthEZ Acquired by Horizon Healthcare Services Inc.

HealthEZ has been acquired by Horizon Blue Cross Blue Shield

6742 HealthEZ NT

Mercalis Merges With PharmaCord

6381 Mercalis NT

Waud Capital Partners Completes Junior Capital Raise for Unifeye Vision Partners

6804 Unifeye Vision Partners - NT

Perimeter Healthcare Acquired by a Private Investor

5652 Perimeter Healthcare NT

HITRUST Receives Growth Investment From Brighton Park Capital

Defense and Space

6257 HITRUST NT SP

Unison Therapy Services Acquired by Ascend Capital Partners

6519 Unison Therapy Services NT

Prescott’s Acquired by Morgan Stanley Capital Partners

6144 Prescott-s Inc. NT

Arlington Capital Partners Acquires TEAM Technologies

6745 Arlington Capital Partners - TEAM Technologies NT

FORLIFE Acquired by Duke Street

6023 GHD Group NT

Eventus WholeHealth Acquired by General Atlantic

6382 Eventus Whole Health NT

Evoco Private Equity Completes Co-Investment Vehicle Syndication​

PCA 6608 Evoco NT

Genetics & IVF Institute Acquired by Amulet Capital Partners 

6113 Genetics and IVF Institute NT

MediQuant Receives Significant Growth Investment from Revelstoke Capital Partners

6045 MediQuant NT

Irrimax Acquired by ARCHIMED

5859 Irrimax NT SP

nexeye Acquired by KKR from 3i

Consumer Multi-Site

6208 Nexeye NT PENDING

TPG Makes Significant Strategic Growth Investment in K2 Medical Research

6516 TPG Growth - K2 Medical Research SP

Caravel Autism Health Acquired By GTCR

6229 Caravel Autism Health NT

Vitalcare Acquired By Serafin

6024Vitalcare(ProjectVitruvius)-SQ-Peg

Compass Community Acquired by Cap10 Partners

6092 Compass Community NT SP

VMG Health Partners with Incline Equity Partners

6292 VMG Health NT

Gauge Capital Partners With Lucent Health

6504 Gauge Capital - Lucent Health NT SP

EHOB, Inc. Acquired by RoundTable Healthcare Partners

5588 EHOB NT SP

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Persistence Capital Partners Completes Continuation Vehicle for MedSpa Partners​

PCA Persistence Capital Partners NT

ABS Capital Completes Continuation Vehicle​

6154 ABS Capital NT

Crowe Healthcare Consulting Receives Majority Investment From TPG

5949 Crowe Healthcare NT

S&S Health

6278 S&S Healthcare Strategies NT

HealthDrive Acquired by Cressey & Company

United States

HealthDrive NT

Greene Group Industries Acquired by Tinicum LP

5870 Greene Group Industries NT

Kelso & Company Acquires Valenz® Health

6078 Valenz Health NT

Ovation Fertility Merged With US Fertility

5857 OvationFertility NT

Amulet Capital Partners Acquires Alliance Clinical Network

5845 Alliance Clinical Network NT

Rhythmlink

5944 Rhythmlink NT

The InterMed Group

5737 InterMed - Project Visor - NT

Pharmalex

Germany

5543 Pharmalex (Project I) NT

QualDerm

5722 QualDerm Partners LLC NT

Celerion

5516 Celerion NT

Bradford Health Services

5520 Bradford Health Services NT

The CM Group

5679 The CM Group

Harris Williams advised People, Pets & Vets, a portfolio company of Cressey & Company, on its sale to VetCor, a portfolio company of Harvest Partners and Cressey & Company. People, Pets & Vets is a veterinary services company with general practice veterinary clinics across the U.S.

People, Pets & Vets

5589 People, Pets & Vets (Project Steamboat) NT

Oak Hill Capital Partners Makes Investment in VetCor

4294 VetCor - Oak Hill Capital NT

Harris Williams advised Monte Nido & Affiliates, a portfolio company of Levine Leichtman Capital Partners, on its sale to Revelstoke Capital Partners. Monte Nido & Affiliates is a leading provider of eating disorder treatment services.

Monte Nido & Affiliates

Harris Williams advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners. Jordi Labs is a leader in analytical chemistry testing, delivering a full suite of regulatory, investigative, and related services to the medical device, pharmaceutical, and other industries.

Jordi Labs

5663 Jordi Labs NT

Harris Williams advised West Coast Dental on its sale to Court Square Capital Partners. West Coast Dental is an established and successful DSO, which was founded in 1991 and has grown to 40 full-service dental centers across the greater Los Angeles area, providing end-to-end, whole family dentistry comprised of general and specialty services including orthodontics, pedodontics, periodontics, endodontics, implants, and oral surgery.

West Coast Dental

5707 West Coast Dental NT

Harris Williams advised Dermatologists of Central States, a portfolio company of Sheridan Capital Partners, on its sale to SkyKnight Capital. Dermatologists of Central States is one of the leading dermatology practices in the U.S.

Dermatologists of Central States

4541 docs dermatologists of central states NT

Harris Williams advised Cerberus on its acquisition of a Clinical Trial Site Management Platform.

Clinical Trial Site Management Platform

5569_artc_project_atlantic_cerberus.png

Harris Williams advised STAXS©, a portfolio company of Silverfleet Capital, on its sale to Franz Haniel & Cie. GmbH. STAXS© is a leading value-add distributor of cleanroom consumables to the life science industry in the Benelux.

STAXS

The Netherlands

5551_staxs_project_purity.png

Harris Williams advised Lifemark Health Group, a portfolio company of Audax Group, on its sale to Loblaw Companies Limited, on behalf of its wholly owned subsidiary Shoppers Drug Mart. Lifemark is the leading provider of outpatient physiotherapy, massage therapy, and occupational therapy as well as chiropractic, mental health, and other ancillary rehabilitation services through its approximately 300 clinics across Canada.

Lifemark Health Group

Canada

4758_lifemark.png

Harris Williams advised Ivy Rehab Network on its sale to funds affiliated with Waud Capital. Ivy Rehab is a national leader in outpatient musculoskeletal and pediatric rehabilitative services with a rapidly growing network of best-in-class outpatient physical, occupational, speech therapy, and ABA clinics located throughout the Northeast, Midwest, and Southeast regions of the United States. 

Ivy Rehab Network

5091_ivy_rehab_project_collins.png

Harris Williams advised Morgan Stanley Capital Partners on its acquisition of SpendMend. SpendMend is a provider of technology-enabled profit recovery and cost containment solutions for healthcare systems.

SpendMend

5600_spendmend.png

Lyniate

Overview

Engagements

Insights